世界の緑膿菌感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pseudomonas Aeruginosa Infection Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5322
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、緑膿菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経鼻、経口、静脈内）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・緑膿菌感染症治療の市場動向
・企業の競争状況、市場シェア
・緑膿菌感染症治療の種類別市場規模と予測2016-2027（経鼻、経口、静脈内）
・緑膿菌感染症治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・緑膿菌感染症治療の北米市場規模2016-2027（アメリカ、カナダ）
・緑膿菌感染症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・緑膿菌感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・緑膿菌感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・緑膿菌感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Allergan、Teva Pharmaceutical Industries、Pfizer、Lupin Pharmaceuticals、AstraZeneca、Merck、Bristol-Myers Squibb、Janssen Pharmaceuticals）
・結論

Market Analysis and Insights: Global Pseudomonas Aeruginosa Infection Treatment Market
The global Pseudomonas Aeruginosa Infection Treatment market size is projected to reach US$ 1216.6 million by 2027, from US$ 933.8 million in 2020, at a CAGR of 3.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pseudomonas Aeruginosa Infection Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pseudomonas Aeruginosa Infection Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pseudomonas Aeruginosa Infection Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pseudomonas Aeruginosa Infection Treatment market.

Global Pseudomonas Aeruginosa Infection Treatment Scope and Market Size
Pseudomonas Aeruginosa Infection Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pseudomonas Aeruginosa Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nasal
Oral
Intravenous

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan
Teva Pharmaceutical Industries
Pfizer
Lupin Pharmaceuticals
AstraZeneca
Merck
Bristol-Myers Squibb
Janssen Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pseudomonas Aeruginosa Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nasal
1.2.3 Oral
1.2.4 Intravenous
1.3 Market by Application
1.3.1 Global Pseudomonas Aeruginosa Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pseudomonas Aeruginosa Infection Treatment Market Perspective (2016-2027)
2.2 Pseudomonas Aeruginosa Infection Treatment Growth Trends by Regions
2.2.1 Pseudomonas Aeruginosa Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pseudomonas Aeruginosa Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Pseudomonas Aeruginosa Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Pseudomonas Aeruginosa Infection Treatment Industry Dynamic
2.3.1 Pseudomonas Aeruginosa Infection Treatment Market Trends
2.3.2 Pseudomonas Aeruginosa Infection Treatment Market Drivers
2.3.3 Pseudomonas Aeruginosa Infection Treatment Market Challenges
2.3.4 Pseudomonas Aeruginosa Infection Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pseudomonas Aeruginosa Infection Treatment Players by Revenue
3.1.1 Global Top Pseudomonas Aeruginosa Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global Pseudomonas Aeruginosa Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Pseudomonas Aeruginosa Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pseudomonas Aeruginosa Infection Treatment Revenue
3.4 Global Pseudomonas Aeruginosa Infection Treatment Market Concentration Ratio
3.4.1 Global Pseudomonas Aeruginosa Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pseudomonas Aeruginosa Infection Treatment Revenue in 2020
3.5 Pseudomonas Aeruginosa Infection Treatment Key Players Head office and Area Served
3.6 Key Players Pseudomonas Aeruginosa Infection Treatment Product Solution and Service
3.7 Date of Enter into Pseudomonas Aeruginosa Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pseudomonas Aeruginosa Infection Treatment Breakdown Data by Type
4.1 Global Pseudomonas Aeruginosa Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global Pseudomonas Aeruginosa Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Pseudomonas Aeruginosa Infection Treatment Breakdown Data by Application
5.1 Global Pseudomonas Aeruginosa Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global Pseudomonas Aeruginosa Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pseudomonas Aeruginosa Infection Treatment Market Size (2016-2027)
6.2 North America Pseudomonas Aeruginosa Infection Treatment Market Size by Type
6.2.1 North America Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2027)
6.3 North America Pseudomonas Aeruginosa Infection Treatment Market Size by Application
6.3.1 North America Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2027)
6.4 North America Pseudomonas Aeruginosa Infection Treatment Market Size by Country
6.4.1 North America Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pseudomonas Aeruginosa Infection Treatment Market Size (2016-2027)
7.2 Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Type
7.2.1 Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2027)
7.3 Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Application
7.3.1 Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2027)
7.4 Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Country
7.4.1 Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Type
8.2.1 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Application
8.3.1 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Region
8.4.1 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size (2016-2027)
9.2 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Type
9.2.1 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Application
9.3.1 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Country
9.4.1 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Type
10.2.1 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Application
10.3.1 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Country
10.4.1 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Pseudomonas Aeruginosa Infection Treatment Introduction
11.1.4 Allergan Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Details
11.2.2 Teva Pharmaceutical Industries Business Overview
11.2.3 Teva Pharmaceutical Industries Pseudomonas Aeruginosa Infection Treatment Introduction
11.2.4 Teva Pharmaceutical Industries Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
11.2.5 Teva Pharmaceutical Industries Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pseudomonas Aeruginosa Infection Treatment Introduction
11.3.4 Pfizer Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Lupin Pharmaceuticals
11.4.1 Lupin Pharmaceuticals Company Details
11.4.2 Lupin Pharmaceuticals Business Overview
11.4.3 Lupin Pharmaceuticals Pseudomonas Aeruginosa Infection Treatment Introduction
11.4.4 Lupin Pharmaceuticals Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
11.4.5 Lupin Pharmaceuticals Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Pseudomonas Aeruginosa Infection Treatment Introduction
11.5.4 AstraZeneca Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Pseudomonas Aeruginosa Infection Treatment Introduction
11.6.4 Merck Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Pseudomonas Aeruginosa Infection Treatment Introduction
11.7.4 Bristol-Myers Squibb Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Janssen Pharmaceuticals
11.8.1 Janssen Pharmaceuticals Company Details
11.8.2 Janssen Pharmaceuticals Business Overview
11.8.3 Janssen Pharmaceuticals Pseudomonas Aeruginosa Infection Treatment Introduction
11.8.4 Janssen Pharmaceuticals Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
11.8.5 Janssen Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pseudomonas Aeruginosa Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nasal
Table 3. Key Players of Oral
Table 4. Key Players of Intravenous
Table 5. Global Pseudomonas Aeruginosa Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pseudomonas Aeruginosa Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pseudomonas Aeruginosa Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pseudomonas Aeruginosa Infection Treatment Market Share by Regions (2016-2021)
Table 9. Global Pseudomonas Aeruginosa Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pseudomonas Aeruginosa Infection Treatment Market Share by Regions (2022-2027)
Table 11. Pseudomonas Aeruginosa Infection Treatment Market Trends
Table 12. Pseudomonas Aeruginosa Infection Treatment Market Drivers
Table 13. Pseudomonas Aeruginosa Infection Treatment Market Challenges
Table 14. Pseudomonas Aeruginosa Infection Treatment Market Restraints
Table 15. Global Pseudomonas Aeruginosa Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pseudomonas Aeruginosa Infection Treatment Market Share by Players (2016-2021)
Table 17. Global Top Pseudomonas Aeruginosa Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudomonas Aeruginosa Infection Treatment as of 2020)
Table 18. Ranking of Global Top Pseudomonas Aeruginosa Infection Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pseudomonas Aeruginosa Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pseudomonas Aeruginosa Infection Treatment Product Solution and Service
Table 22. Date of Enter into Pseudomonas Aeruginosa Infection Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pseudomonas Aeruginosa Infection Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Pseudomonas Aeruginosa Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pseudomonas Aeruginosa Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pseudomonas Aeruginosa Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pseudomonas Aeruginosa Infection Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Pseudomonas Aeruginosa Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pseudomonas Aeruginosa Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Pseudomonas Aeruginosa Infection Treatment Product
Table 65. Allergan Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. Teva Pharmaceutical Industries Company Details
Table 68. Teva Pharmaceutical Industries Business Overview
Table 69. Teva Pharmaceutical Industries Pseudomonas Aeruginosa Infection Treatment Product
Table 70. Teva Pharmaceutical Industries Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021) & (US$ Million)
Table 71. Teva Pharmaceutical Industries Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Pseudomonas Aeruginosa Infection Treatment Product
Table 75. Pfizer Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Lupin Pharmaceuticals Company Details
Table 78. Lupin Pharmaceuticals Business Overview
Table 79. Lupin Pharmaceuticals Pseudomonas Aeruginosa Infection Treatment Product
Table 80. Lupin Pharmaceuticals Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021) & (US$ Million)
Table 81. Lupin Pharmaceuticals Recent Development
Table 82. AstraZeneca Company Details
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Pseudomonas Aeruginosa Infection Treatment Product
Table 85. AstraZeneca Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021) & (US$ Million)
Table 86. AstraZeneca Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Pseudomonas Aeruginosa Infection Treatment Product
Table 90. Merck Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Pseudomonas Aeruginosa Infection Treatment Product
Table 95. Bristol-Myers Squibb Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021) & (US$ Million)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Janssen Pharmaceuticals Company Details
Table 98. Janssen Pharmaceuticals Business Overview
Table 99. Janssen Pharmaceuticals Revenue in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021) & (US$ Million)
Table 100. Janssen Pharmaceuticals Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pseudomonas Aeruginosa Infection Treatment Market Share by Type: 2020 VS 2027
Figure 2. Nasal Features
Figure 3. Oral Features
Figure 4. Intravenous Features
Figure 5. Global Pseudomonas Aeruginosa Infection Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Pseudomonas Aeruginosa Infection Treatment Report Years Considered
Figure 10. Global Pseudomonas Aeruginosa Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pseudomonas Aeruginosa Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pseudomonas Aeruginosa Infection Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Pseudomonas Aeruginosa Infection Treatment Market Share by Regions (2022-2027)
Figure 14. Global Pseudomonas Aeruginosa Infection Treatment Market Share by Players in 2020
Figure 15. Global Top Pseudomonas Aeruginosa Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudomonas Aeruginosa Infection Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pseudomonas Aeruginosa Infection Treatment Revenue in 2020
Figure 17. Global Pseudomonas Aeruginosa Infection Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Pseudomonas Aeruginosa Infection Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pseudomonas Aeruginosa Infection Treatment Market Share by Type (2016-2027)
Figure 21. North America Pseudomonas Aeruginosa Infection Treatment Market Share by Application (2016-2027)
Figure 22. North America Pseudomonas Aeruginosa Infection Treatment Market Share by Country (2016-2027)
Figure 23. United States Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pseudomonas Aeruginosa Infection Treatment Market Share by Type (2016-2027)
Figure 27. Europe Pseudomonas Aeruginosa Infection Treatment Market Share by Application (2016-2027)
Figure 28. Europe Pseudomonas Aeruginosa Infection Treatment Market Share by Country (2016-2027)
Figure 29. Germany Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Share by Region (2016-2027)
Figure 39. China Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pseudomonas Aeruginosa Infection Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Pseudomonas Aeruginosa Infection Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Pseudomonas Aeruginosa Infection Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pseudomonas Aeruginosa Infection Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pseudomonas Aeruginosa Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Allergan Revenue Growth Rate in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
Figure 59. Teva Pharmaceutical Industries Revenue Growth Rate in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
Figure 61. Lupin Pharmaceuticals Revenue Growth Rate in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
Figure 65. Janssen Pharmaceuticals Revenue Growth Rate in Pseudomonas Aeruginosa Infection Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

緑膿菌感染症治療のグローバル市場：規模・現状・予測2019-2025

Global Pseudomonas Aeruginosa Infection Treatment Market Size, Status and Forecast 2019-2025
QYR9NV18332 2019年11月18日 90Pages
※当調査レポートでは、緑膿菌感染症治療の世界市場について調査・分析し、緑膿菌感染症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（鼻、経口、静脈内）、用途別（病院薬局、小売薬局、オンライン薬局）...

緑膿菌感染症治療のグローバル市場：規模・現状・予測2019-2025

世界のボツリヌス菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Clostridium Botulinum Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4028 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ボツリヌス菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗毒素療法、細心気道管理、人工呼吸補助）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の小児HIV感染症治療市場規模・現状・予測（2021年-2027年）

Global Pediatric HIV Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5935 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、小児HIV感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（無症状、軽症、中症、重症）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他）、主要地域別市場規模（北米、...

世界のブドウ球菌感染症治療市場規模・現状・予測（2021年-2027年）

Global Staphylococcal Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4899 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ブドウ球菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射液）、用途別市場規模（黄色ブドウ球菌感染症、表皮ブドウ球菌感染症、サプロコッカス感染症）、主要地域別市場規模（北米、アメ...

世界の羊膜感染症治療市場規模・現状・予測（2021年-2027年）

Global Intra-amniotic Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5807 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、羊膜感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゲンタマイシン、クリンダマイシン、メトロニダゾール、その他）、用途別市場規模（病院・専門クリニック、外来手術センター、病院薬局、小売薬局、...

世界のスポロトリクスシェンキー感染症治療市場規模・現状・予測（2021年-2027年）

Global Sporothrix Schenckii Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4897 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、スポロトリクスシェンキー感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イトラコナゾール薬、アムホテリシンB薬、ヨウ化カリウム飽和溶液（SSKI）、手術、その他）、用途別市場規模（病院、専門...

世界の上気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Upper Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6058 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、上気道感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬 (NSAIDs) ＆鼻充血除去薬、その他）、用途別市場規模（鼻炎、副鼻腔炎、鼻咽頭炎、喉頭蓋炎、喉頭炎...

緑膿菌肺炎治療薬のグローバル市場調査 2019年

Global Pseudomonas Aeruginosa Pneumonia Drug Market Professional Survey Report 2019
QYR9NV10765 2019年11月14日 107Pages
※本調査レポートは、緑膿菌肺炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アエルシン、EV-035、MEDI-3902、パノバクマブ、その他に、用途...

緑膿菌肺炎治療薬のグローバル市場調査 2019年

緑膿菌感染症治療のグローバル市場：規模・現状・予測2019-2025 In 2018, the global Pseudomonas Aeruginosa Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Pseudomonas Aeruginosa Infection Treatment status, future forecast, grow…
緑膿菌感染症治療のグローバル市場：規模・現状・予測2019-2025 In 2018, the global Pseudomonas Aeruginosa Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Pseudomonas Aeruginosa Infection Treatment status, future forecast, grow…
緑膿菌肺炎治療薬のグローバル市場調査 2019年 The global Pseudomonas Aeruginosa Pneumonia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pseudomonas Aeruginosa Pneumonia Drug volume and value at global level, regional level and company le…
緑膿菌肺炎治療薬のグローバル市場調査 2019年 The global Pseudomonas Aeruginosa Pneumonia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pseudomonas Aeruginosa Pneumonia Drug volume and value at global level, regional level and company le…
世界の小児HIV感染症治療市場規模・現状・予測（2021年-2027年） Over 1.8 million children across the globe are affected from HIV, while only half of these have access to the antiretroviral therapy (ART), according to the UNICEF Market Analysis and Insights: Global Pediatric HIV Infection Treatment Market The global Pediatric HIV Infection Treatment market size i…